<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02826174</url>
  </required_header>
  <id_info>
    <org_study_id>Closed PKP</org_study_id>
    <nct_id>NCT02826174</nct_id>
  </id_info>
  <brief_title>Topical Anesthesia for Closed PKP vs Retrobulbar Anesthesia for Open-sky PKP</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wenzhou Medical University</source>
  <brief_summary>
    <textblock>
      Penetrating keratoplasty (PKP) is an open-sky surgery that fundamentally has not changed for
      more than 100 years. Because conventional PKP is associated with the potential for the
      development of devastating complications such as expulsive suprachoroidal hemorrhage and
      endophthalmitis, we modified the technique to one that is a closed surgery under topical
      anesthesia with the anterior chamber maintained to achieve favorable results. Topical
      anesthesia is an attractive alternative to traditional injection local anesthesia since the
      potentially serious complications associated with retrobulbar and peribulbar anesthesia can
      be avoided. The closed PKP procedure with the stable anterior chamber essentially changes the
      open nature of conventional PKP. The advantages, i.e., decreased surgical risks,
      postoperative complications, and surgical difficulties, make PKP viable in most complicated
      cases.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>best corrected visual acuity</measure>
    <time_frame>preoperative</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>best corrected visual acuity</measure>
    <time_frame>1 week after PKP</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>best corrected visual acuity</measure>
    <time_frame>2 weeks after PKP</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>best corrected visual acuity</measure>
    <time_frame>1 month after PKP</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>best corrected visual acuity</measure>
    <time_frame>3 months after PKP</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>best corrected visual acuity</measure>
    <time_frame>6 months after PKP</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Endothelial cell density</measure>
    <time_frame>1 week after PKP</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial cell density</measure>
    <time_frame>2 weeks after PKP</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial cell density</measure>
    <time_frame>1 month after PKP</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial cell density</measure>
    <time_frame>3 months after PKP</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial cell density</measure>
    <time_frame>6 months after PKP</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Corneal Opacity</condition>
  <condition>Keratitis, Herpetic</condition>
  <condition>Corneal Ulcer</condition>
  <condition>Corneal Dystrophies, Hereditary</condition>
  <arm_group>
    <arm_group_label>closed PKP under topical anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a closed corneal transplantation under topical anesthesia with the anterior chamber maintained</description>
  </arm_group>
  <arm_group>
    <arm_group_label>open-sky PKP under retrobulbar anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>an open-sky corneal transplantation under retrobulbar anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anti-Rejection Agents</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Anti-Rejection Agents for both groups</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anti-Inflammatory Agents</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Anti-Inflammatory Agents for both groups</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>closed PKP under topical anesthesia</intervention_name>
    <description>a closed corneal transplantation under topical anesthesia with the anterior chamber maintained</description>
    <arm_group_label>closed PKP under topical anesthesia</arm_group_label>
    <arm_group_label>Anti-Rejection Agents</arm_group_label>
    <arm_group_label>Anti-Inflammatory Agents</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>open-sky PKP under retrobulbar anesthesia</intervention_name>
    <description>an open-sky corneal transplantation under retrobulbar anesthesia</description>
    <arm_group_label>open-sky PKP under retrobulbar anesthesia</arm_group_label>
    <arm_group_label>Anti-Rejection Agents</arm_group_label>
    <arm_group_label>Anti-Inflammatory Agents</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anti-Rejection Agents</intervention_name>
    <description>Anti-Rejection Agents for both groups</description>
    <arm_group_label>closed PKP under topical anesthesia</arm_group_label>
    <arm_group_label>open-sky PKP under retrobulbar anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anti-Inflammatory Agents</intervention_name>
    <description>Anti-Inflammatory Agents for both groups</description>
    <arm_group_label>closed PKP under topical anesthesia</arm_group_label>
    <arm_group_label>open-sky PKP under retrobulbar anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  active bacterial keratitis, for which ulceration progressed despite maximum
             antibacterial medication;

          -  refractory fungal keratitis that did not respond to antifungal agents;

          -  nonactive HSK, for which corneal opacities with or without new vessels involved the
             optical zone;

          -  ocular acid burn and thermal burn with partial limbal deficiency (50% or less) that,
             after more than half a year of preoperative treatment, showed reepithelialization and
             less than 2 quadrants limbal neovascularization.

        Exclusion Criteria:

          -  Patients with keratolimbal allograft transplantation, total limbal stem cell
             deficiency secondary to ocular burns, and other ocular diseases (ie, amblyopia,
             age-related cataract, glaucoma, macular edema, and mac ular degeneration) were
             excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eye Hospital, Wenzhou Medical College</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325027</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>qian gui, MD</last_name>
      <phone>8613600643736</phone>
      <email>389997168@qq.com</email>
    </contact>
    <contact_backup>
      <last_name>qinxiang zheng, PhD</last_name>
      <phone>8613738379810</phone>
    </contact_backup>
    <investigator>
      <last_name>Jinyang Li, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Chen W, Ren Y, Zheng Q, Li J, Waller SG. Securing the anterior chamber in penetrating keratoplasty: an innovative surgical technique. Cornea. 2013 Sep;32(9):1291-5. doi: 10.1097/ICO.0b013e31829954c5.</citation>
    <PMID>23860425</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2016</study_first_submitted>
  <study_first_submitted_qc>July 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2016</study_first_posted>
  <last_update_submitted>July 4, 2016</last_update_submitted>
  <last_update_submitted_qc>July 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wenzhou Medical University</investigator_affiliation>
    <investigator_full_name>Jinyang Li</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratitis</mesh_term>
    <mesh_term>Corneal Ulcer</mesh_term>
    <mesh_term>Corneal Opacity</mesh_term>
    <mesh_term>Keratitis, Herpetic</mesh_term>
    <mesh_term>Corneal Dystrophies, Hereditary</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Anti-Inflammatory Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

